The global Regenerative medicine market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America will continue to dominate the global market in the forecast period. However, Asia is expected to witness the highest CAGR, with the growth in this market centred at China, Japan and India. Increasing research activities in Asian countries, availability of funding for research, and the establishment of biobanks and research centers are some factor More
